{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:17:13Z","timestamp":1783477033521,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["2019GSF108255"],"award-info":[{"award-number":["2019GSF108255"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH575"],"award-info":[{"award-number":["ZR2024QH575"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1463"],"award-info":[{"award-number":["ZR2025MS1463"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.isci.2025.114152","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:17:06Z","timestamp":1763659026000},"page":"114152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy and safety of interval and post-reTURBT intravesical therapy for bladder cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Dongshan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapeng","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiyuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuolei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1630-125X","authenticated-orcid":false,"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114152_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11255-023-03867-9","article-title":"Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?","volume":"56","author":"Beijert","year":"2024","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.isci.2025.114152_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133789","article-title":"Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review","volume":"13","author":"Chiujdea","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2025.114152_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2024.08.001","article-title":"Bladder-sparing Therapy for Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection","volume":"86","author":"Li","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.euo.2024.10.012","article-title":"Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guerin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group","volume":"8","author":"D'Andrea","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib8","first-page":"3422","article-title":"Pilot study of intravesical instillation of two new generation anthracycline antibiotics in prevention of superficial bladder cancer recurrence","volume":"123","author":"Chen","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.isci.2025.114152_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib10","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.114152_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/bco2.363","article-title":"Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant Therapy","volume":"5","author":"Ajami","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.isci.2025.114152_bib12","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1002\/cam4.3513","article-title":"Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysis","volume":"9","author":"Lu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2025.114152_bib13","doi-asserted-by":"crossref","first-page":"62.e7","DOI":"10.1016\/j.urolonc.2024.07.016","article-title":"Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors","volume":"43","author":"Dahmen","year":"2025","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib14","article-title":"Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database Study","volume":"6","author":"Seo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114152_bib15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2011.12.056","article-title":"National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer","volume":"187","author":"Cookson","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib16","first-page":"1937","article-title":"Exploring the Immunoresponse in Bladder","volume":"13","author":"Ruiz-Lorente","year":"2024","journal-title":"Cancer Immunotherapy Cells"},{"key":"10.1016\/j.isci.2025.114152_bib17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3389\/fonc.2019.01270","article-title":"Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications","volume":"9","author":"Joseph","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2425529","article-title":"Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer","volume":"20","author":"Peng","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.114152_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1200\/JCO.2010.31.5721","article-title":"Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer","volume":"29","author":"Choudhury","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.114152_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14740338.2024.2431587","article-title":"Pharmacovigilance insights into drug-induced cystitis: analysis of FDA data from 2004 to 2024","volume":"24","author":"Zheng","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.isci.2025.114152_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajco.13931","article-title":"Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical study","volume":"20","author":"Wang","year":"2024","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114152_bib25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14740338.2024.2393283","article-title":"Adverse drug reactions of intravesical instillation therapy for bladder cancer: based on FDA adverse event reporting system","volume":"24","author":"Liu","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.isci.2025.114152_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euros.2025.05.011","article-title":"Potential of Urinary Mutation and Methylation Biomarkers in Selecting Candidates for Repeat Transurethral Resection of Bladder Tumor in Non-muscle-invasive Bladder Cancer: A Prospective Multicenter Study","volume":"77","author":"Yang","year":"2025","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.isci.2025.114152_bib27","first-page":"178","article-title":"Urinary Tumor DNA-based Liquid Biopsy in Bladder Cancer Management: A Systematic Review","volume":"S2405\u20134569","author":"Lee","year":"2025","journal-title":"Eur. Urol. Focus"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225024137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225024137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:31:46Z","timestamp":1783474306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225024137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589004225024137"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114152","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of interval and post-reTURBT intravesical therapy for bladder cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114152"}}